Clinical Trial Update: Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) [NA]

View source ↗

Summary

A completed clinical trial evaluated the pharmacokinetics and safety of tigecycline for treating Clostridioides difficile infection–associated diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Gary E. Stein, Pharm.D. | Conditions: Diarrhea, Clostridium Difficile | NA | Status: COMPLETED | Results posted: 2013-10-14